| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CPT.186 |
| P698 | PubMed publication ID | 26179624 |
| P2093 | author name string | N R Klatt | |
| R K Reeves | |||
| A Burgener | |||
| P2860 | cites work | Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 |
| Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22 | Q24648620 | ||
| The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection | Q24676095 | ||
| Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection | Q27318086 | ||
| Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection | Q27322468 | ||
| In vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infection | Q27330386 | ||
| Therapeutic potential of fecal microbiota transplantation | Q28298108 | ||
| A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | Q28299539 | ||
| Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 | ||
| Neutrophil recruitment and function in health and inflammation | Q29616689 | ||
| Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens | Q29617432 | ||
| The nature of the principal type 1 interferon-producing cells in human blood | Q29619763 | ||
| MMP9 modulates tight junction integrity and cell viability in human airway epithelia | Q30487603 | ||
| An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. | Q31147419 | ||
| Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections | Q33680743 | ||
| Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication | Q33872468 | ||
| Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism | Q33889154 | ||
| Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection | Q33943429 | ||
| Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. | Q33984007 | ||
| Residual immune dysregulation syndrome in treated HIV infection | Q34020121 | ||
| The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. | Q34152180 | ||
| Reduction of immune activation with chloroquine therapy during chronic HIV infection | Q34296062 | ||
| Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection | Q34315572 | ||
| Immune activation and HIV persistence: implications for curative approaches to HIV infection | Q34351320 | ||
| Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer | Q34414152 | ||
| Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16⁺ NK cell-like phenotype and correlates with HIV viral load. | Q34427488 | ||
| Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection | Q34430215 | ||
| Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial | Q34451794 | ||
| Changes in Natural Killer cell activation and function during primary HIV-1 Infection | Q34551274 | ||
| Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease | Q34555620 | ||
| CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. | Q34562235 | ||
| Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection | Q34634195 | ||
| Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation | Q34682171 | ||
| New treatments for COPD. | Q34742138 | ||
| Plasma levels of soluble CD14 independently predict mortality in HIV infection | Q34764002 | ||
| Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection | Q35230224 | ||
| Dysbiotic bacteria translocate in progressive SIV infection. | Q35542433 | ||
| Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis | Q35553567 | ||
| Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression | Q35564886 | ||
| Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection | Q35617066 | ||
| Gut epithelial barrier and systemic inflammation during chronic HIV infection | Q35648710 | ||
| Matrix metalloproteinases as modulators of inflammation and innate immunity | Q35852281 | ||
| SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosa | Q36486814 | ||
| Microbial translocation, immune activation, and HIV disease | Q36501286 | ||
| Altered distribution of mucosal NK cells during HIV infection. | Q37087265 | ||
| Regulation of TH17 cells in the mucosal surfaces | Q37442153 | ||
| Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes | Q37638959 | ||
| Anti-interferon alpha treatment in SLE. | Q38097198 | ||
| HIV-specific antibody immunity mediated through NK cells and monocytes | Q38160066 | ||
| The role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against HIV. | Q38170193 | ||
| An evidence-based review of the mechanism of action, efficacy, and safety of biologic therapies in the treatment of psoriasis and psoriatic arthritis | Q38447571 | ||
| Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial | Q38484316 | ||
| Neutrophil-derived JAML inhibits repair of intestinal epithelial injury during acute inflammation. | Q39016237 | ||
| In vivo natural killer cell depletion during primary simian immunodeficiency virus infection in rhesus monkeys | Q39766807 | ||
| Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study | Q40377079 | ||
| Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells | Q40805771 | ||
| Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study). | Q40964230 | ||
| Short communication: Plasmacytoid dendritic cells from HIV-1 Elite Controllers maintain a gut-homing phenotype associated with immune activation | Q41667625 | ||
| Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients | Q42254144 | ||
| Simian immunodeficiency virus infection induces expansion of alpha4beta7+ and cytotoxic CD56+ NK cells | Q42551573 | ||
| Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. | Q43233439 | ||
| Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers | Q43481738 | ||
| Multi-functional plasmacytoid dendritic cells redistribute to gut tissues during simian immunodeficiency virus infection | Q45350854 | ||
| Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense | Q46197286 | ||
| JAK1/STAT3 activation directly inhibits IL-12 production in dendritic cells by preventing CDK9/P-TEFb recruitment to the p35 promoter | Q46735113 | ||
| Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. | Q51405927 | ||
| Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization. | Q54323405 | ||
| Innate Immunity in HIV Infection | Q56879617 | ||
| Inhibition of TGF-β Signaling by IL-15: A New Role for IL-15 in the Loss of Immune Homeostasis in Celiac Disease | Q57218272 | ||
| A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers | Q57766050 | ||
| Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals | Q57971847 | ||
| Human neutrophil defensins and their effect on epithelial cells | Q83735253 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 381-386 | |
| P577 | publication date | 2015-07-14 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Targeting the gastrointestinal tract to develop novel therapies for HIV. | |
| P478 | volume | 98 |
Search more.